Related Experiment Video
Updated: Feb 6, 2026

Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice
Published on: January 6, 2018
Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast
Ibrahim Omar1, Gali Guterman-Ram2, Dolev Rahat3
1The Lautenberg Center for Immunology and Cancer Research, The Biomedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School Jerusalem, Jerusalem, Israel.
Abstract:
Osteoclasts are the bone resorbing cells that derive from myeloid progenitor cells. Although there have been recent advancements in the ability to identify osteoclast progenitors, very little is known about the molecular mechanisms governing their homeostasis. Here, by analyzing the normalized phylogenetic profiles of the Schlafen (Slfn) gene family, we found that it co-evolved with osteoclast-related genes. Following these findings, we used a Slfn2 loss-of-function mutant mouse, elektra, to study the direct role of Slfn2 in osteoclast development and function. Slfn2eka/eka mice exhibited a profound increase in their cancellous bone mass and a significant reduction in osteoclast numbers. In addition, monocyte cultures from the bone marrow of Slfn2eka/eka mice showed a reduction in osteoclast number and total resorption area. Finally, we show that the bone marrow of Slfn2eka/eka mice have significantly less CD11b-Ly6Chi osteoclast precursors. Overall, our data suggest that Slfn2 is required for normal osteoclast differentiation and that loss of its function in mice results in an osteopetrotic phenotype.
Insights
The Schlafen (Slfn) gene family co-evolved with osteoclast genes. Loss of Slfn2 in mice leads to increased bone mass and fewer osteoclasts, suggesting Slfn2 is crucial for normal osteoclast differentiation.
Area of Science:
- Bone Biology
- Cellular and Molecular Medicine
- Genetics and Genomics
Background:
- Osteoclasts are key bone-resorbing cells derived from myeloid progenitors.
- Molecular mechanisms regulating osteoclast progenitor homeostasis remain largely unknown.
- Phylogenetic analysis revealed co-evolution of the Schlafen (Slfn) gene family with osteoclast-related genes.
Purpose of the Study:
- To investigate the role of Schlafen (Slfn) gene family, specifically Slfn2, in osteoclast development and function.
- To elucidate the molecular mechanisms governing osteoclast homeostasis.
- To determine if Slfn2 deficiency impacts bone mass and osteoclast activity.
Main Methods:
- Analysis of normalized phylogenetic profiles of the Schlafen (Slfn) gene family.
- Utilized Slfn2 loss-of-function mutant mice (elektra).
- Performed bone marrow monocyte cultures and assessed osteoclast differentiation and resorption, and quantified osteoclast precursor populations (CD11b-Ly6Chi).
Main Results:
- Slfn2 loss-of-function mutant mice (Slfn2eka/eka) displayed significantly increased cancellous bone mass.
- A profound reduction in osteoclast numbers and total resorption area was observed in Slfn2eka/eka mice.
- Bone marrow from Slfn2eka/eka mice contained significantly fewer CD11b-Ly6Chi osteoclast precursors.
Conclusions:
- Schlafen (Slfn)2 is essential for normal osteoclast differentiation and function.
- Loss of Slfn2 function in mice results in an osteopetrotic phenotype.
- Slfn2 plays a critical role in regulating osteoclast homeostasis and bone metabolism.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Decreasing Function
Viral Mutations
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...

